In summary, the hypermethylation of the PRDM2/RIZ gene promoter is also one of the pathogenic mechanisms of neurological diseases, such as meningiomas and gliomas, suggesting that PRDM2/RIZ may be one of the targets for the diagnosis and prevention of neurological diseases. This evidence concerns the gene PRDM2 and meningioma.